This scientific statement is a granular contribution to a major cardiovascular issue, illuminating nuances of the "generally recognized as safe" (GRAS) FDA designation. One would expect the relevant Thoracic Associations in North America and Europe to contribute to this debate.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Endovascular
June 23, 2022
March 30, 2022
Interesting case-control study on variations of aortovascular compliance
February 26, 2022
This newly released AHA scientific statement offers a comprehensive review of the latest imaging and measurement techniques for patients with chronic aortic dissection and clarifies the need for standardized measurements and reporting for lifelong surveillance.
February 18, 2022
The American Heart Association has released a scientific statement on imaging and surveillance of chronic aortic dissection, expounding the state-of-the-art imaging and measurement techniques (CT, MR and echocardiography), and clarifying the need for standardized measurements and reporting for lifelong surveillance.
February 16, 2022
A useful short review accompanied by media , related to the background of the ARISE Study. The esteemed authors discuss the potential endovascular options for zone 0 for inoperable Acute Aortic Syndromes.
January 14, 2022
A scholarly update on the previous (2016) guidelines, with an interesting Chapter 9 Gaps in evidence and future perspectives. The guidelines have been extensively reviewed by European and other experts. The authors insist on the only advisory value of their conclusions. Understandably, there is no mention of venous ECMO.
November 9, 2021
A good-size Terumo-sponsored RCT that is set to impact on decisions to discontinue DAPT early after PCI with absorbable stent, a change that will somehow decrease the surgical risk of bleeding in the event of salvage CABG.
November 1, 2021
An extremely useful and free-access update on a major vascular entity. The 'Areas of Uncertainty' is a particularly useful chapter, discussing the available technology and its current supra-renal limitations and the emerging solutions.
October 22, 2021
A brief focused commentary on a recent medium size Japanese series of succesful surgery for Acute Aortic Syndrome. The limitations of the series presented in well- written Uchida manuscript( and already to the last AATS Meeting) are being explored, and the commentators' allusion to the need for randomised trial is evident.
October 8, 2021
Objective: The aim of the study was to determine cause-specific mortality in TBAD and to evaluate the clinical characteristics associated with aorta-related and non aorta-related mortality.